Status:
COMPLETED
Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
Lead Sponsor:
Organon and Co
Conditions:
Seasonal Allergic Rhinitis
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
This study will assess the treatment effect of montelukast versus placebo over a 2 week period in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active comparator.
Eligibility Criteria
Inclusion
- Patient has a documented history of season allergic rhinitis symptoms that flare up during the study season
- Patient is a nonsmoker
- Patient is in good general health
Exclusion
- Patient is hospitalized
- Patient is a woman who is \<8 weeks postpartum or is breast-feeding
- Patient has had major surgery in the past 4 weeks
- Patient intends to move or vacation away during the study
- Patient is a current or past abuser of alcohol or illicit drugs
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2001
Estimated Enrollment :
1214 Patients enrolled
Trial Details
Trial ID
NCT00972738
Start Date
April 1 2001
End Date
July 1 2001
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.